Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| NHI | PRESS-RELEASE | neutral | 2/10 | NHI issued a brief investor update via press release directing investors to a web link, with no new material financial d | Aug 10, 2026 |
| BBIO | PRESS-RELEASE | mixed | 6/10 | BridgeBio reported Q2 2026 total revenues of $243.7M (+120.5% YoY), driven by $222.4M in Attruby net product revenue (+2 | Aug 10, 2026 |
| SEPN | PRESS-RELEASE | neutral | 4/10 | Septerna reported Q2 2026 financial results highlighting a net loss of $13.0M (EPS -$0.29) vs consensus of -$0.48, a 39. | Aug 10, 2026 |
| OPRA | PRESS-RELEASE | neutral | 1/10 | Opera Limited announced it will report its Q2 2026 results on August 19, 2026. | Aug 10, 2026 |
| RIOT | PRESS-RELEASE | mixed | 7/10 | Riot Platforms reported Q2 2026 revenue of $174.2M, up 14% YoY, but GAAP net loss of -$237.2M vs. $219.5M net income in | Aug 10, 2026 |
| YCBD | PRESS-RELEASE | neutral | 1/10 | cbdMD, Inc. announced it will host a conference call on June 30, 2026 to discuss its Q3 results. | Aug 10, 2026 |
| SNFCA | PRESS-RELEASE | neutral | 5/10 | Security National Financial Corporation reported Q4 2025 EPS of $0.53 with no consensus estimates available for comparis | Aug 10, 2026 |
| SLI | PRESS-RELEASE | bullish | 6/10 | Standard Lithium reported a narrower-than-expected Q2 loss (EPS -$0.01 vs -$0.03 consensus) and highlighted major operat | Aug 10, 2026 |
| LINC | PRESS-RELEASE | bullish | 6/10 | Lincoln Educational Services reported Q2 2026 revenue of $142.6M (+22.4% YoY) and GAAP diluted EPS of $0.06, beating con | Aug 10, 2026 |
| CNDT | PRESS-RELEASE | bearish | 6/10 | Conduent reported Q2 2026 revenue of $531M, down 11.9% YoY, with adjusted EBITDA margin compressing to 3.0% from 3.8%. A | Aug 10, 2026 |
| SGRY | PRESS-RELEASE | neutral | 5/10 | Surgery Partners reported Q2 2026 revenue of $848.9M (+2.7% YoY) and adjusted EPS of $0.10, beating consensus of $0.07 b | Aug 10, 2026 |
| GCMG | PRESS-RELEASE | mixed | 5/10 | GCM Grosvenor reported Q2 2026 Adjusted Net Income per share of $0.19, beating consensus of $0.18 by 3.3%, while GAAP ne | Aug 10, 2026 |
| AIM | PRESS-RELEASE | bearish | 5/10 | AIM ImmunoTech reported Q2 2026 net loss of $(3.8M) or $(0.43) per share, a 258% miss vs consensus of $(0.12). The compa | Aug 10, 2026 |
| FRHC | PRESS-RELEASE | mixed | 6/10 | Freedom Holding Corp. reported net revenue of $732.5M for Q1 FY2027, up 40% YoY, driven by 60% brokerage segment growth | Aug 10, 2026 |
| HRTX | PRESS-RELEASE | bearish | 7/10 | Heron Therapeutics reported Q2 2026 revenue of $37.7M (missed consensus of $42.2M by 10.7%) and GAAP EPS of -$0.03 (miss | Aug 10, 2026 |
| NYAX | PRESS-RELEASE | mixed | 6/10 | Nayax Q2 2026 revenue of $122.6M (+28% YoY) beat consensus by 1.3%, while adjusted diluted EPS of $0.144 beat the $0.13 | Aug 10, 2026 |
| CRC | PRESS-RELEASE | mixed | 5/10 | CRC reported Q2 2026 adjusted EPS of $0.99, missing the $1.37 consensus by 28%, while revenue before derivatives of $1.0 | Aug 10, 2026 |
| TLS | PRESS-RELEASE | bullish | 7/10 | Telos Corporation reported Q2 2026 revenue of $47.7M (+33% YoY), beating consensus of $45.2M, and GAAP net income of $0. | Aug 10, 2026 |
| BWMN | PRESS-RELEASE | bullish | 8/10 | Bowman Consulting Group (BWMN) reported Q2 2026 adjusted diluted EPS of $0.62, beating consensus of $0.46 by 35%, with g | Aug 10, 2026 |
| FSTR | PRESS-RELEASE | mixed | 6/10 | L.B. Foster reported Q2 2026 GAAP EPS of $0.30, missing consensus of $0.41 by 26.8%, while revenue of $138.6M beat estim | Aug 10, 2026 |
| COGT | PRESS-RELEASE | neutral | 5/10 | Cogent Biosciences reported Q2 2026 net loss of $96.4 million (EPS $-0.60 vs consensus $-0.56, a 6.2% miss) as R&D and G | Aug 10, 2026 |
| SHFS | PRESS-RELEASE | bearish | 5/10 | Safe Harbor Financial reported Q2 2026 revenue of $1.93M, up 4.8% YoY, driven by a 50.7% increase in loan program income | Aug 10, 2026 |
| NTHI | PRESS-RELEASE | mixed | 6/10 | NeOnc reported Q2 2026 EPS of -$0.58, well below the -$0.16 consensus, with net loss widening to $14.2M on higher R&D sp | Aug 10, 2026 |
| DAKT | PRESS-RELEASE | bearish | 6/10 | Daktronics reported Q4 2026 EPS of $0.27, a 23.9% miss vs. the $0.35 consensus, and revenue of $231.3M, missing the $231 | Aug 10, 2026 |
| ESEA | PRESS-RELEASE | neutral | 1/10 | Euroseas announced it will report its Q2 2026 results on August 13, 2026. | Aug 10, 2026 |
| CD | PRESS-RELEASE | bearish | 7/10 | Chaince Digital announced a registered direct offering of 30,560,000 ordinary shares at approximately $0.53 per share fo | Aug 10, 2026 |
| EHLD | PRESS-RELEASE | neutral | 1/10 | Euroholdings Ltd. announced it will report its Q2 2026 results on August 12, 2026. | Aug 10, 2026 |
| KPTI | PRESS-RELEASE | neutral | 1/10 | Karyopharm Therapeutics Inc. announced it will report its Q2 2026 results on August 13, 2026. | Aug 10, 2026 |
| KEEL | PRESS-RELEASE | mixed | 6/10 | Keel Infrastructure reported Q2 2026 revenue of $30M, down 50% YoY, and a GAAP loss of $0.11 per share, swinging from a | Aug 10, 2026 |
| AXSM | PRESS-RELEASE | mixed | 6/10 | Axsome reported Q2 2026 net product revenue of $218.4M (+46% YoY), beating the $221.8M consensus, but GAAP EPS of -$1.26 | Aug 10, 2026 |